Research Material Overview
Semax is a heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro, offered as a lyophilized powder for in-vitro laboratory research. It appears in our neurological research category with its product specifications, reference identifiers and the report on file. Supplier analytical documentation is reviewed before release and published where applicable.
Product Specifications
| Physical Form | Lyophilized powder |
|---|---|
| Vial Size | 5 mg / 10 mg |
| Purity Specification | ≥98% by HPLC |
| Analysis | Third-party HPLC (MS identity where reported) |
Analytical Documentation
Our sources provide third-party analytical testing (HPLC, with mass-spec identity where reported). The report on file for Semax is listed below and can be opened with the Access COA button on this page.
| Certificate of Analysis | 10 mg — Report batch 2026 · Janoshik · 99.007% HPLC Full Semax certificate results |
|---|
Analytical reports on file
- Semax 10 mg — report batch 2026 — 99.007% purity — Janoshik, 19 May 2026
These are the analytical reports currently on file for this product. Reports may be updated as new documentation is received, and each can be opened with the Access COA buttons on this page. For questions about the documentation for your order, contact us with your order number.
Compound Identity / Reference Information
| CAS Number | 80714-61-0 |
|---|---|
| Molecular Formula | C37H51N9O10S |
| Molecular Weight | 813.92 g/mol |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
Storage
Store lyophilized at −20 °C, protected from light.
Research Use
For laboratory research use only. Not for human or veterinary consumption.
This material is not a drug, food, dietary supplement, cosmetic, or medical device, and is not intended to diagnose, treat, cure, or prevent any condition. It is intended solely for qualified research professionals.
